A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus

ClinicalTrials.gov ID: NCT06118515

Public ClinicalTrials.gov record NCT06118515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 8:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Pharmacokinetic and Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus Disease

Study identification

NCT ID: NCT06118515
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Enrollment: 12 participants

Conditions and interventions

Conditions

Congenital Cytomegalovirus Infection

Interventions

Letermovir Drug

Drug

Eligibility (public fields only)

Age range: 0 Days to 90 Days
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 18, 2025
Primary completion: May 14, 2026
Completion: Aug 30, 2026
Last update posted: May 14, 2026

2025 – 2026

United States locations

U.S. sites: 10
U.S. states: 10
U.S. cities: 10

Facility	City	State	ZIP	Site status
Children's of Alabama Child Health Research Unit (CHRU)	Birmingham	Alabama	35233-0011	Recruiting
Children's National Medical Center - Sheikh Zayed Campus - Infectious Disease	Washington D.C.	District of Columbia	20010-2916	Withdrawn
Emory University School of Medicine	Atlanta	Georgia	30322-1014	Recruiting
University of Louisville School of Medicine - Norton Children's Hospital - Infectious Diseases	Louisville	Kentucky	40202	Withdrawn
Louisiana State University Health Shreveport - Infectious Diseases	Shreveport	Louisiana	71101	Withdrawn
University of Minnesota - Pediatric Infectious Disease	Minneapolis	Minnesota	55454	Withdrawn
SUNY Upstate Medical University Hospital - Pediatrics	Syracuse	New York	13210-2342	Withdrawn
Nationwide Children's Hosp.-Neonatology-Ctr. for Perinatal Rsrch.	Columbus	Ohio	43205-2664	Withdrawn
University of Texas Southwestern Medical Center - Pediatrics	Dallas	Texas	75390-9063	Withdrawn
Medical College of Wisconsin	Milwaukee	Wisconsin	53226	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06118515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 14, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06118515 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →